233 related articles for article (PubMed ID: 21220790)
1. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G; Horvath G; Szabo O; Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
[TBL] [Abstract][Full Text] [Related]
2. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
[TBL] [Abstract][Full Text] [Related]
3. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
4. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
[TBL] [Abstract][Full Text] [Related]
5. [Acute hepatitis due to hepatitis C virus infection in the adult population].
Hernández Febles M; Rodríguez San Román JL; Martín Suárez JM; Pena-López MJ
Gastroenterol Hepatol; 2009 Dec; 32(10):677-80. PubMed ID: 19815311
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
Bate JP; Colman AJ; Frost PJ; Shaw DR; Harley HA
J Gastroenterol Hepatol; 2010 Jul; 25(7):1276-80. PubMed ID: 20594255
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme D
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
[No Abstract] [Full Text] [Related]
8. [Treatment of hepatitis C in intravenous drug users].
Filoche B
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
[No Abstract] [Full Text] [Related]
9. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
[TBL] [Abstract][Full Text] [Related]
10. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
Matheï C; Buntinx F; Van Damme P
J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
[No Abstract] [Full Text] [Related]
11. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
12. Clearance of hepatitis C virus after newly acquired infection in injection drug users.
Jauncey M; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson W; Kaldor JM; van Beek I; Dore GJ
J Infect Dis; 2004 Oct; 190(7):1270-4. PubMed ID: 15346337
[TBL] [Abstract][Full Text] [Related]
13. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.
van de Laar TJ; Langendam MW; Bruisten SM; Welp EA; Verhaest I; van Ameijden EJ; Coutinho RA; Prins M
J Med Virol; 2005 Dec; 77(4):509-18. PubMed ID: 16254983
[TBL] [Abstract][Full Text] [Related]
14. [Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary].
Gervain J; Simon G; Papp I; Szabóné BK
Orv Hetil; 2001 Jun; 142(25):1315-9. PubMed ID: 11488211
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hallinan R; Byrne A; Amin J; Dore GJ
J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
[TBL] [Abstract][Full Text] [Related]
16. Acute hepatitis C virus infection.
Chung RT
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S14-7. PubMed ID: 16265608
[TBL] [Abstract][Full Text] [Related]
17. [Low prevalence of hepatitis C virus infection in a prisoner population from Maracaibo, Venezuela].
Monsalve-Castillo F; Chacín-Bonilla L; Atencio RJ; Porto LD; Costa-León LA; Estévez JE; Callejas-Valero DE
Biomedica; 2009 Dec; 29(4):647-52. PubMed ID: 20440463
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in intravenous drug users.
Harder J; Walter E; Riecken B; Ihling C; Bauer TM
Clin Microbiol Infect; 2004 Aug; 10(8):768-70. PubMed ID: 15301685
[TBL] [Abstract][Full Text] [Related]
19. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
[No Abstract] [Full Text] [Related]
20. Diagnosis of depression in former injection drug users with chronic hepatitis C.
Scott JD; Wang CC; Coppel E; Lau A; Veitengruber J; Roy-Byrne P
J Clin Gastroenterol; 2011; 45(5):462-7. PubMed ID: 21293293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
